Should Sword Health prioritize expanding its musculoskeletal care offerings or focus on improving existing programs for better patient outcomes?

Introduction

The trade-off Sword Health faces is whether to prioritize expanding its musculoskeletal care offerings or focus on improving existing programs for better patient outcomes. This decision involves balancing growth through new services against enhancing the quality and effectiveness of current offerings. I'll analyze this trade-off by examining the product ecosystem, potential impacts, key metrics, and experimental approaches to inform a strategic recommendation.

Step 1

Clarifying Questions (3 minutes)

• Based on Sword Health's current market position, I'm thinking expansion might be crucial for growth. Could you share our current market share and how it compares to competitors?

Why it matters: Helps determine if expansion or improvement is more critical for competitiveness. Expected answer: Moderate market share with room for growth. Impact on approach: High market share might favor improvement, while low share could prioritize expansion.

• Considering patient outcomes, I'm assuming we have data on the effectiveness of our existing programs. Can you provide insights into our current patient satisfaction and recovery rates?

Why it matters: Indicates whether improvement of existing programs is urgently needed. Expected answer: Good satisfaction but room for improvement in recovery rates. Impact on approach: Low satisfaction or recovery rates would strongly favor improving existing programs.

• Looking at our technical capabilities, I'm curious about our platform's scalability. How easily can we integrate new musculoskeletal care offerings into our current system?

Why it matters: Affects the feasibility and timeline of expansion. Expected answer: Moderately scalable with some integration challenges. Impact on approach: High scalability would support expansion, while low scalability might favor improvement.

• Regarding our team structure, I'm wondering about our current resource allocation. What's the split between teams working on existing programs versus new product development?

Why it matters: Indicates our current focus and capacity for either option. Expected answer: 70% on existing programs, 30% on new development. Impact on approach: A high allocation to existing programs might suggest a need for expansion focus.

• Considering our strategic roadmap, I'm curious about any upcoming partnerships or market expansions. Are there any significant business developments in the next 6-12 months that could influence this decision?

Why it matters: Aligns the decision with broader company strategy. Expected answer: Potential partnership with a major healthcare provider. Impact on approach: A significant partnership might favor expansion to meet new market needs.